Gene Editing is the ability to make highly specific changes in the DNA sequence of a living organism, essentially customizing its genetic makeup. It demonstrates great potential in gene research, gene therapy and genetic improvement. The Gene Editing concept includes major US-listed companies whose businesses are involved in gene editing.
No Data
Is Vertex Pharmaceuticals Stock a Millionaire Maker?
The Motley Fool9minutes ago
Buy Rating on Vertex Pharmaceuticals Fueled by Promising IgAN Therapy and Strategic Acquisition
TipRanks18:45 ET
ProKidney Sinks 15%+, Snapping Five-Session Run-Up That Saw Biotech More Than Double in Less Than a Week
PROK sank more than 15% Thursday as the biotech snapped a five-session winning streak that saw its price rise some 130% in just days.
Jerry Kronenberg16:56 ET
Reitmans (Canada) Limited Reports Fiscal 2024 and Fourth Quarter Fiscal 2024 Financial Results
Stockhouse 16:30 ET
Global Biochips Market Size and Share to Grow by 2030, Accesses DelveInsight | Key Players in the Market - Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Qiagen, Abbott, Hoffmann La-Roche, Cepheid
New York, USA, April 18, 2024 (GLOBE NEWSWIRE) -- Global Biochips Market Size and Share to Grow by 2030, Accesses DelveInsight | Key Players in the Market - Thermo Fisher Scientific, Agilent Technologies, GE
GlobeNewswire13:00 ET
Crispr Therapeutics Is Maintained at Buy by Citigroup
Crispr Therapeutics Is Maintained at Buy by Citigroup
Dow Jones12:22 ET